Financial News
Articles published by Arrowhead Pharmaceuticals Inc.
Via Business Wire
Tickers
ARWR
Via Business Wire
Tickers
ARWR
Via Business Wire
Tickers
ARWR
Arrowhead Pharmaceuticals Gains Full Rights to NASH Candidate ARO-PNPLA3 with Promising Phase 1 Results
February 15, 2023
Via Business Wire
Tickers
ARWR
Arrowhead Pharmaceuticals to Present at 41st Annual J.P. Morgan Healthcare Conference
December 21, 2022
Via Business Wire
Tickers
ARWR
Via Business Wire
Tickers
ARWR
Arrowhead Pharmaceuticals and Vivo Capital Launch Joint Venture Aimed at Greater China Market
April 25, 2022
Via Business Wire
Tickers
ARWR
Via Business Wire
Tickers
ARWR
Via Business Wire
Tickers
ARWR
Arrowhead Earns $10 Million Phase 1 Milestone Payment
September 28, 2021
Via Business Wire
Tickers
ARWR
Via Business Wire
Tickers
ARWR
Via Business Wire
Tickers
ARWR
Via Business Wire
Tickers
ARWR
Via Business Wire
Tickers
ARWR
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.